Immune Boost Injectable naturally enhances the body’s natural defense system in order to ward off infection and illness. This treatment is made from Thymosin Alpha 1 (generic ZADAXIN®), a novel peptide clinically proven to lower the risk of infection from flu, viruses, or bacteria.
TA1, the active ingredient in this treatment, is a naturally circulating peptide protein specifically produced in the body to boost immune response. This clinically proven treatment consists of 10 mini-injections given over 30-days to help increase your odds of staying healthy—by triggering the release of T cells to attack and kill viral or bacterial infections—and to support a weakened immune system. If you are experiencing increased risk, exposure, or high stress, or if your immune system is already compromised, this treatment can enhance your body’s natural defenses.
Immune Boost Injectable is a micro-thin, easy-to-use self-injection given just under the skin of the abdomen every 3 days.
The product will provide 30 days of treatment. Continued treatment is recommended during prolonged exposure to infectious agents for up to 12 months.
Thymosin Alpha 1 (TA1) / 5ml
A naturally circulating hormone peptide proven to be effective as an immune system boost for protection against bacteria, fungi, or viruses that could invade your body.
Those who are in need of an immune system boost, particularly during times of increased exposure to viruses or other infectious agents.
Immune Boost Injectable is administered with a small needle, so those who are uncomfortable self-injecting or having a partner inject should not use this product. Patients with allergies to injected peptides as well as those with uncontrolled high or low blood pressure (hypertension/hypotension), a history of heart attacks, strokes or unstable angina should avoid use.
This treatment should not be used by anyone on a medical immunosuppressant therapy (ie, post-transplant patients).
No side effects have been reported other than some mild to moderate irritation, itching or redness at the injection site. No adverse drug interactions have been observed.